LimFlow System
FDA premarket approval P220025 · decided 2023-09-11
Approval details
- PMA number
- P220025
- Trade name
- LimFlow System
- Generic name
- Stent graft, infrapopliteal, venous arterialization
- Applicant
- LimFlow, Inc.
- Date received
- 2022-10-31
- Decision date
- 2023-09-11
- Days to decision
- 315 days
- Decision code
- APPR
- Product code
- QWN
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- San Jose, CA
- Statement
- Approval for The LimFlow System. The device is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| LimFlow Vector (K260188) | LimFlow, Inc. | 2026-03-18 |
| LimFlow ARC (K251376) | LimFlow, Inc. | 2025-05-31 |
| LimFlow V-Ceiver (K242776) | LimFlow, Inc. | 2025-02-14 |
| LimFlow Vector (K221902) | LimFlow, Inc. | 2022-12-21 |
| LimFlow ARC (K221541) | LimFlow, Inc. | 2022-08-31 |
| LimFlow V-Ceiver (K222083) | LimFlow, Inc. | 2022-08-09 |